Nuveen Asset Management’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.42M | Sell |
1,315,771
-355,953
| -21% | -$2.01M | ﹤0.01% | 1762 |
|
|
2024
Q3 | $8.09M | Buy |
1,671,724
+861,227
| +106% | +$4.17M | ﹤0.01% | 1741 |
|
|
2024
Q2 | $3.96M | Sell |
810,497
-64,722
| -7% | -$316K | ﹤0.01% | 2069 |
|
|
2024
Q1 | $11.6M | Buy |
875,219
+416,971
| +91% | +$5.54M | ﹤0.01% | 1507 |
|
|
2023
Q4 | $6.39M | Buy |
458,248
+279,604
| +157% | +$3.9M | ﹤0.01% | 1841 |
|
|
2023
Q3 | $2.37M | Buy |
178,644
+2,740
| +2% | +$36.3K | ﹤0.01% | 2224 |
|
|
2023
Q2 | $3.3M | Buy |
175,904
+15,180
| +9% | +$285K | ﹤0.01% | 2107 |
|
|
2023
Q1 | $2.32M | Sell |
160,724
-27,750
| -15% | -$400K | ﹤0.01% | 2272 |
|
|
2022
Q4 | $3.65M | Sell |
188,474
-109,910
| -37% | -$2.13M | ﹤0.01% | 2094 |
|
|
2022
Q3 | $10.3M | Buy |
298,384
+148,964
| +100% | +$5.12M | ﹤0.01% | 1457 |
|
|
2022
Q2 | $2.28M | Buy |
149,420
+16,879
| +13% | +$258K | ﹤0.01% | 2371 |
|
|
2022
Q1 | $2.91M | Buy |
132,541
+76,644
| +137% | +$1.68M | ﹤0.01% | 2339 |
|
|
2021
Q4 | $1.83M | Sell |
55,897
-4,100
| -7% | -$134K | ﹤0.01% | 2606 |
|
|
2021
Q3 | $2.82M | Buy |
+59,997
| New | +$2.82M | ﹤0.01% | 2514 |
|